Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 12, Issue 4, Pages 311-328
http://dx.doi.org/10.1155/NP.2005.311

The Role of Insulin, Insulin Growth Factor, and Insulin-Degrading Enzyme in Brain Aging and Alzheimer's Disease

1School of Psychology, University of Ottawa, Ontario, Ottawa K1N 6N5, Canada
2School of Psychology, University of Ottawa, 145 Jean-Jacques Lussier, Room 352, Ontario, Ottawa KIN 6N5, Canada

Copyright © 2005 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [87 citations]

The following is the list of published articles that have cited the current article.

  • Vincenzo Giordano, Gianfranco Peluso, Maurizio Iannuccelli, Paola Benatti, Raffaella Nicolai, and Menotti Calvani, “Systemic and Brain Metabolic Dysfunction as a New Paradigm for Approaching Alzheimer’s Dementia,” Neurochemical Research, vol. 32, no. 4-5, pp. 555–567, 2006. View at Publisher · View at Google Scholar
  • S.J. Pasquaré, G.A. Salvador, and N.M. Giusto, “Age-associated changes of insulin action on the hydrolysis of diacylglycerol generated from phosphatidic acid,” Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, vol. 144, no. 3, pp. 311–318, 2006. View at Publisher · View at Google Scholar
  • John G. Mielke, Katarina Nicolitch, Vanessa Avellaneda, Karen Earlam, Tarun Ahuja, Geoffrey Mealing, and Claude Messier, “Longitudinal study of the effects of a high-fat diet on glucose regulation, hippocampal function, and cerebral insulin sensitivity in C57BL/6 mice,” Behavioural Brain Research, vol. 175, no. 2, pp. 374–382, 2006. View at Publisher · View at Google Scholar
  • Roger S McIntyre, Joanna K Soczynska, Hanna O Woldeyohannes, Gary F Lewis, Lawrence A Leiter, Glenda M MacQueen, Andrew Miranda, Don Fulgosi, Jakub Z Konarski, and Sidney H Kennedy, “Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?,” Expert Opinion on Pharmacotherapy, vol. 8, no. 11, pp. 1615–1628, 2007. View at Publisher · View at Google Scholar
  • Santiago Rodriguez, Tom R. Gaunt, and Ian N. M. Day, “Molecular genetics of human growth hormone, insulin-like growth factors and their pathways in common disease,” Human Genetics, vol. 122, no. 1, pp. 1–21, 2007. View at Publisher · View at Google Scholar
  • Matthew Townsend, Tapan Mehta, and Dennis J. Selkoe, “Soluble Aβ inhibits specific signal transduction cascades common to the insulin receptor pathway,” Journal of Biological Chemistry, vol. 282, no. 46, pp. 33305–33312, 2007. View at Publisher · View at Google Scholar
  • Otto Tschritter, Anita M. Hennige, Hubert Preissl, Katarina Porubska, Silke A. Schäfer, Werner Lutzenberger, Fausto Machicao, Niels Birbaumer, Andreas Fritsche, and Hans-Ulrich Häring, “Cerebrocortical beta activity in overweight humans responds to insulin detemir,” PLoS ONE, vol. 2, no. 11, 2007. View at Publisher · View at Google Scholar
  • Matthew D. Parrott, and Carol E. Greenwood, “Dietary influences on cognitive function with aging: From high-fat diets to healthful eating,” Annals of the New York Academy of Sciences, vol. 1114, pp. 389–397, 2007. View at Publisher · View at Google Scholar
  • Roger S. McIntyre, Joanna K. Soczynska, Jakub Z. Konarski, Hanna O. Woldeyohannes, Candy W.Y. Law, Andrew Miranda, Don Fulgosi, and Sidney H. Kennedy, “Should depressive syndromes be reclassified as "metabolic syndrome type II"?,” Annals of Clinical Psychiatry, vol. 19, no. 4, pp. 257–264, 2007. View at Publisher · View at Google Scholar
  • Giovanni Meola, and Valeria Sansone, “Cerebral involvement in myotonic dystrophies,” Muscle & Nerve, vol. 36, no. 3, pp. 294–306, 2007. View at Publisher · View at Google Scholar
  • Rukhsana Sultana, and D. Allan Butterfield, “Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: Insights into the progression of this dementing disorder,” Journal of Alzheimer's Disease, vol. 12, no. 1, pp. 61–72, 2007. View at Publisher · View at Google Scholar
  • Anurag Kuhad, and Kanwaljit Chopra, “Neurobiology of diabetic encephalopathy,” Drugs of The Future, vol. 33, no. 9, pp. 763–775, 2008. View at Publisher · View at Google Scholar
  • Gary Landreth, Qingguang Jiang, Shweta Mandrekar, and Michael Heneka, “PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease,” Neurotherapeutics, vol. 5, no. 3, pp. 481–489, 2008. View at Publisher · View at Google Scholar
  • Maria Garcia-Fernandez, Gloria Delgado, Juan Enrique Puche, Salvador Gonzalez-Baron, and Inma Castilla Cortazar, “Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism, and oxidative damage in aging rats,” Endocrinology, vol. 149, no. 5, pp. 2433–2442, 2008. View at Publisher · View at Google Scholar
  • Qingguang Jiang, Michael Heneka, and Gary E Landreth, “The Role of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) in Alzheimer’s Disease,” CNS Drugs, vol. 22, no. 1, pp. 1–14, 2008. View at Publisher · View at Google Scholar
  • Claes Ohlsson, Subburaman Mohan, Klara Sjögren, Åsa Tivesten, Jörgen Isgaard, Olle Isaksson, John-Olov Jansson, and Johan Svensson, “The role of liver-derived insulin-like growth factor-I,” Endocrine Reviews, vol. 30, no. 5, pp. 494–535, 2009. View at Publisher · View at Google Scholar
  • Bogdan O. Popescu, Emil C. Toescu, Laurentiu M. Popescu, Ovidiu Bajenaru, Dafin F. Muresanu, Marianne Schultzberg, and Nenad Bogdanovic, “Blood-brain barrier alterations in ageing and dementia,” Journal of the Neurological Sciences, vol. 283, no. 1-2, pp. 99–106, 2009. View at Publisher · View at Google Scholar
  • T. Zhang, B.-S. Pan, B. Zhao, L.-M. Zhang, Y.-L. Huang, and F.-Y. Sun, “Exacerbation of poststroke dementia by type 2 diabetes is associated with synergistic increases of β-secretase activation and β-amyloid generation in rat brains,” Neuroscience, vol. 161, no. 4, pp. 1045–1056, 2009. View at Publisher · View at Google Scholar
  • Wei-Qin Zhao, Pascale N. Lacor, Hui Chen, Mary P. Lambert, Michael J. Quon, Grant A. Krafft, and William L. Klein, “Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric Aβ,” Journal of Biological Chemistry, vol. 284, no. 28, pp. 18742–18753, 2009. View at Publisher · View at Google Scholar
  • Olivia Bibollet-Bahena, Qiao-Ling Cui, and Guillermina Almazan, “The insulin-like growth factor-1 axis and its potential as a therapeutic target in central nervous system (CNS) disorders,” Central Nervous System Agents in Medicinal Chemistry, vol. 9, no. 2, pp. 95–109, 2009. View at Publisher · View at Google Scholar
  • Ke Ning, Lisa C. Miller, Hilary A. Laidlaw, Kenneth R. Watterson, Jennifer Gallagher, Calum Sutherland, and Michael L.J. Ashford, “Leptin-dependent phosphorylation of PTEN mediates actin restructuring and activation of ATP-sensitive K+ channels,” Journal of Biological Chemistry, vol. 284, no. 14, pp. 9331–9340, 2009. View at Publisher · View at Google Scholar
  • Han-Kyu Lee, Pravir Kumar, Qinghao Fu, Kenneth M. Rosen, and Henry W. Querfurth, “The insulin/Akt signaling pathway is targeted by intracellular β-amyloid,” Molecular Biology of the Cell, vol. 20, no. 5, pp. 1533–1544, 2009. View at Publisher · View at Google Scholar
  • Daniel J. Lamport, Clare L. Lawton, Michael W. Mansfield, and Louise Dye, “Impairments in glucose tolerance can have a negative impact on cognitive function: A systematic research review,” Neuroscience and Biobehavioral Reviews, vol. 33, no. 3, pp. 394–413, 2009. View at Publisher · View at Google Scholar
  • Rip, Schenk, and De Boer, “Differential receptor-mediated drug targeting to the diseased brain,” Expert Opinion on Drug Delivery, vol. 6, no. 3, pp. 227–237, 2009. View at Publisher · View at Google Scholar
  • Ricardo José Gomes, Camila Aparecida Machado de Oliveira, Carla Ribeiro, Clécia Soares de Alencar Mota, Leandro Pereira Moura, Lilian Mari Marcondes Cesar Tognoli, José Alexandre Curiacos de Almeida Leme, Eliete Luciano, and Maria Alice Rostom de Mello, “Effects of exercise training on hippocampus concentrations of insulin and IGF-1 in diabetic rats,” Hippocampus, vol. 19, no. 10, pp. 981–987, 2009. View at Publisher · View at Google Scholar
  • Ronald A. Cohen, Athena Poppas, Daniel E. Forman, Karin F. Hoth, Andreana P. Haley, John Gunstad, Angela L. Jefferson, David F. Tate, Robert H. Paul, Lawrence H. Sweet, Mokato Ono, Beth A. Jerskey, and Marie Gerhard-Herman, “Vascular and cognitive functions associated with cardiovascular disease in the elderly,” Journal of Clinical and Experimental Neuropsychology, vol. 31, no. 1, pp. 96–110, 2009. View at Publisher · View at Google Scholar
  • Antonino Belfiore, Francesco Frasca, Giuseppe Pandini, Laura Sciacca, and Riccardo Vigneri, “Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease,” Endocrine Reviews, vol. 30, no. 6, pp. 586–623, 2009. View at Publisher · View at Google Scholar
  • Chikari Takeo, Kazuhiro Ikeda, Kuniko Horje-Inoue, and Satoshi Inoue, “Identification of Igf2, Igfbp2 and Enpp2 as estrogen-responsive genes in rat hippocampus,” Endocrine Journal, vol. 56, no. 1, pp. 113–120, 2009. View at Publisher · View at Google Scholar
  • Susana Cardoso, Sonia Correia, Renato X. Santos, Cristina Carvalho, Maria S. Santos, Catarina R. Oliveira, George Perry, Mark A. Smith, Xiongwei Zhu, and Paula I. Moreira, “Insulin is a Two-Edged Knife on the Brain,” Journal Of Alzheimers Disease, vol. 18, no. 3, pp. 483–507, 2009. View at Publisher · View at Google Scholar
  • Sathyajit S. Bandaru, Kristen Lin, Stephanie L. Roming, Ramana Vellipuram, and Jacob P. Harney, “Effects of PI3K inhibition and low docosahexaenoic acid on cognition and behavior,” Physiology & Behavior, vol. 100, no. 3, pp. 239–244, 2010. View at Publisher · View at Google Scholar
  • Peter Riederer, Jasmin Bartl, Gerd Laux, and Edna Grünblatt, “Diabetes Type II: A Risk Factor for Depression–Parkinson–Alzheimer?,” Neurotoxicity Research, vol. 19, no. 2, pp. 253–265, 2010. View at Publisher · View at Google Scholar
  • Ken A. Morris, Qing Chang, Eric G. Mohler, and Paul E. Gold, “Age-related memory impairments due to reduced blood glucose responses to epinephrine,” Neurobiology of Aging, vol. 31, no. 12, pp. 2136–2145, 2010. View at Publisher · View at Google Scholar
  • Henry W. Querfurth, and Frank M. LaFerla, “Alzheimer's Disease,” New England Journal of Medicine, vol. 362, no. 4, pp. 329–344, 2010. View at Publisher · View at Google Scholar
  • Halper, “Growth factors as active participants in carcinogenesis: A perspective,” Veterinary Pathology, vol. 47, no. 1, pp. 77–97, 2010. View at Publisher · View at Google Scholar
  • Malcolm A. Leissring, Enrico Malito, Sabrine Hedouin, Lael Reinstatler, Tomoko Sahara, Samer O. Abdul-Hay, Shakeel Choudhry, Ghulam M. Maharvi, Abdul H. Fauq, Malwina Huzarska, Philip S. May, Sungwoon Choi, Todd P. Logan, Benjamin E. Turk, Lewis C. Cantley, Marika Manolopoulou, Wei-Jen Tang, Ross L. Stein, Gregory D. Cuny, and Dennis J. Selkoe, “Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin,” PLoS ONE, vol. 5, no. 5, 2010. View at Publisher · View at Google Scholar
  • Laura D. Baker, Laura L. Frank, Karen Foster-Schubert, Pattie S Green, Charles W. Wilkinson, Anne McTiernan, Brenna A. Cholerton, Stephen R. Plymate, Mark A. Fishel, G. Stennis Watson, Glen E. Duncan, Pankaj D. Mehta, and Suzanne Craft, “Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 22, no. 2, pp. 569–579, 2010. View at Publisher · View at Google Scholar
  • Domenico Bosco, Antonietta Fava, Massimiliano Plastino, Tiziana Montalcini, and Arturo Pujia, “Possible implications of insulin resistance and glucose metabolism in Alzheimer’s disease pathogenesis,” Journal of Cellular and Molecular Medicine, vol. 15, no. 9, pp. 1807–1821, 2011. View at Publisher · View at Google Scholar
  • Vincenza Cifarelli, Drew Hays, and Stephen D. Hursting, “Insulin, insulin-like growth factor-1 and neurodegeneration,” International Journal of Endocrinology and Metabolism, vol. 9, no. 3, pp. 422–424, 2011. View at Publisher · View at Google Scholar
  • Rupinder K. Sodhi, Nirmal Singh, and Amteshwar S. Jaggi, “Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer’s disease,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 384, no. 2, pp. 115–124, 2011. View at Publisher · View at Google Scholar
  • Chung-Jung Chiu, Yvette P. Conley, Michael B. Gorin, Gary Gensler, Chao-Qiang Lai, Fu Shang, and Allen Taylor, “Associations between Genetic Polymorphisms of Insulin-like Growth Factor Axis Genes and Risk for Age-Related Macular Degeneration,” Investigative Ophthalmology & Visual Science, vol. 52, no. 12, pp. 9099–9107, 2011. View at Publisher · View at Google Scholar
  • Julie E. Simpson, Paul G. Ince, Pamela J. Shaw, Paul R. Heath, Rohini Raman, Claire J. Garwood, Catherine Gelsthorpe, Lynne Baxter, Gillian Forster, Fiona E. Matthews, Carol Brayne, and Stephen B. Wharton, “Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer's pathology and APOE genotype,” Neurobiology of Aging, vol. 32, no. 10, pp. 1795–1807, 2011. View at Publisher · View at Google Scholar
  • Molly Fyfe, Aarthi Raman, Sushma Sharma, Mark L. Hudes, and Sharon E. Fleming, “Insulin resistance and self-perceived scholastic competence in inner-city, overweight and obese, African American children,” Physiology & Behavior, vol. 102, no. 1, pp. 36–41, 2011. View at Publisher · View at Google Scholar
  • Enrique J. de la Rosa, and Flora de Pablo, “Proinsulin: from hormonal precursor to neuroprotective factor,” Frontiers In Molecular Neuroscience, vol. 4, 2011. View at Publisher · View at Google Scholar
  • Mei-Hua Qu, Chun-Yan Fang, Xiu-Rong Zhang, Chun-Zhen Zhao, Shu-Mei Mao, and Zhi-Qin Gao, “Type 2 Diabetes and Mild Cognitive Impairment*,” Progress In Biochemistry And Biophysics, vol. 39, no. 8, pp. 791–795, 2012. View at Publisher · View at Google Scholar
  • Auriel A. Willette, Barbara B. Bendlin, Ricki J. Colman, Erik K. Kastman, Aaron S. Field, Andrew L. Alexander, Aadhavi Sridharan, David B. Allison, Rozalyn Anderson, Mary-Lou Voytko, Joseph W. Kemnitz, Richard H. Weindruch, and Sterling C. Johnson, “Calorie restriction reduces the influence of glucoregulatory dysfunction on regional brain volume in aged rhesus monkeys,” Diabetes, vol. 61, no. 5, pp. 1036–1042, 2012. View at Publisher · View at Google Scholar
  • Naoki Yamamoto, Teruhiko Matsubara, Kazuya Sobue, Mamoru Tanida, Rika Kasahara, Kaori Naruse, Hideo Taniura, Toshinori Sato, and Kenji Suzuki, “Brain insulin resistance accelerates Aβ fibrillogenesis by inducing GM1 ganglioside clustering in the presynaptic membranes,” Journal of Neurochemistry, vol. 121, no. 4, pp. 619–628, 2012. View at Publisher · View at Google Scholar
  • S. M. Resnick, R. D. Jackson, K. Yaffe, S. A. Shumaker, M. A. Espeland, R. Casanova, B. E. Klein, S. A. Gaussoin, J. E. Rossouw, R. Wallace, M. Haan, and A. E. Millen, “Cognitive function and retinal and ischemic brain changes The Women's Health Initiative,” Neurology, vol. 78, no. 13, pp. 942–949, 2012. View at Publisher · View at Google Scholar
  • Suzanne M. de la Monte, “Contributions of Brain Insulin Resistance and Deficiency in Amyloid-Related Neurodegeneration in Alzheimerʼs Disease,” Drugs, vol. 72, no. 1, pp. 49–66, 2012. View at Publisher · View at Google Scholar
  • Suzanne M. de la Monte, “Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease,” Current Alzheimer Research, vol. 9, no. 1, pp. 35–66, 2012. View at Publisher · View at Google Scholar
  • Zhiyou Cai, Yu Zhao, and Bin Zhao, “Roles of glycogen synthase kinase 3 in Alzheimer's disease,” Current Alzheimer Research, vol. 9, no. 7, pp. 864–879, 2012. View at Publisher · View at Google Scholar
  • Alexis M. Stranahan, and Mark P. Mattson, “Metabolic Reserve as a Determinant of Cognitive Aging,” Journal Of Alzheimers Disease, vol. 30, pp. S5–S13, 2012. View at Publisher · View at Google Scholar
  • Suzanne M. de la Monte, and Ming Tong, “Brain Metabolic Dysfunction at the Core of Alzheimer's Disease,” Biochemical Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Suzanne M de la Monte, “Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art,” Expert Opinion on Drug Delivery, pp. 1–11, 2013. View at Publisher · View at Google Scholar
  • Wolfgang Froestl, Andreas Muhs, and Andrea Pfeifer, “Cognitive enhancers (nootropics). Part 2: Drugs interacting with enzymes,” Journal of Alzheimer's Disease, vol. 33, no. 3, pp. 547–658, 2013. View at Publisher · View at Google Scholar
  • Hui Zhang, Ying Hao, Bradley Manor, Peter Novak, William Milberg, Jue Zhang, Jing Fang, and Vera Novak, “Intranasal Insulin Enhanced Resting-State Functional Connectivity of Hippocampal Regions in Type 2 Diabetes,” Diabetes, vol. 64, no. 3, pp. 1025–1034, 2014. View at Publisher · View at Google Scholar
  • Takashi Iwamoto, and Yasuo Ouchi, “Emerging evidence of insulin-like growth factor 2 as a memory enhancer: a unique animal model of cognitive dysfunction with impaired adult neurogenesis,” Reviews in The Neurosciences, vol. 25, no. 4, pp. 559–574, 2014. View at Publisher · View at Google Scholar
  • Juvenal A. Ríos, Pedro Cisternas, Marco Arrese, Salesa Barja, and Nibaldo C. Inestrosa, “Is Alzheimer's Disease related to Metabolic Syndrome? A Wnt Signaling Conundrum,” Progress in Neurobiology, 2014. View at Publisher · View at Google Scholar
  • Suzanne M. de la Monte, “Type 3 diabetes is sporadic Alzheimer's disease: Mini-review,” European Neuropsychopharmacology, 2014. View at Publisher · View at Google Scholar
  • Tamer Ibrahim Salem, Omminea Alsaied Abdullah, and Amer Mohammed Abdulhamid, “Polymorphism of Insulin-Like Growth Factor-II Gene in Primary Open Angle Glaucoma and its Effect on Treatment,” International Journal of Pharmacology, vol. 10, no. 6, pp. 328–333, 2014. View at Publisher · View at Google Scholar
  • Mubashir Hassan, Sheikh A. Sehgal, and Sajid Rashid, “Regulatory cascade of neuronal loss and glucose metabolism,” CNS and Neurological Disorders - Drug Targets, vol. 13, no. 7, pp. 1232–1245, 2014. View at Publisher · View at Google Scholar
  • Woori Kim, Haneul Noh, Yenarae Lee, Jeha Jeon, Arthi Shanmugavadivu, Donna L. McPhie, Kwang-Soo Kim, Bruce M. Cohen, Hyemyung Seo, and Kai C. Sonntag, “MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons,” Molecular Neurobiology, 2014. View at Publisher · View at Google Scholar
  • Ricardo Rueda, “The role of Complex Lipids in Attaining Metabolic Health,” Current Cardiovascular Risk Reports, vol. 8, no. 1, 2014. View at Publisher · View at Google Scholar
  • Michelle W. Voss, Lucas J. Carr, Rachel Clark, and Timothy Weng, “Revenge of the "sit" II: Does lifestyle impact neuronal and cognitive health through distinct mechanisms associated with sedentary behavior and physical activity?,” Mental Health and Physical Activity, 2014. View at Publisher · View at Google Scholar
  • Sumeet Sood, Kunal Jain, and K. Gowthamarajan, “Intranasal therapeutic strategies for management of Alzheimer’s disease,” Journal of Drug Targeting, pp. 1–16, 2014. View at Publisher · View at Google Scholar
  • Kerstin T. S. Wirz, Stella Keitel, Dick F. Swaab, Joost Verhaagen, and Koen Bossers, “Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?,” Journal of Alzheimers Disease, vol. 38, no. 4, pp. 719–740, 2014. View at Publisher · View at Google Scholar
  • Jogender Mehla, Balwantsinh C. Chauhan, and Neelima B. Chauhan, “Experimental Induction of Type 2 Diabetes in Aging-Accelerated Mice Triggered Alzheimer-Like Pathology and Memory Deficits,” Journal of Alzheimers Disease, vol. 39, no. 1, pp. 145–162, 2014. View at Publisher · View at Google Scholar
  • Gauri S. Desai, Chen Zheng, Thangiah Geetha, Suresh T. Mathews, B. Douglas White, Kevin W. Huggins, Claire A. Zizza, Tom L. Broderick, and Jeganathan Ramesh Babu, “The Pancreas-Brain Axis: Insight into Disrupted Mechanisms Associating Type 2 Diabetes and Alzheimer's Disease,” Journal of Alzheimers Disease, vol. 42, no. 2, pp. 347–356, 2014. View at Publisher · View at Google Scholar
  • Auriel A. Willette, Barbara B. Bendlin, Erika J. Starks, Alex C. Birdsill, Sterling C. Johnson, Bradley T. Christian, Ozioma C. Okonkwo, Asenath La Rue, Bruce P. Hermann, Rebecca L. Koscik, Erin M. Jonaitis, Mark A. Sager, and Sanjay Asthana, “Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease,” Jama Neurology, vol. 72, no. 9, pp. 1013–1020, 2015. View at Publisher · View at Google Scholar
  • Maria Niures P.S. Matioli, and Ricardo Nitrini, “Mechanisms linking brain insulin resistance to Alzheimer's disease,” Dementia & Neuropsychologia, vol. 9, no. 2, pp. 96–102, 2015. View at Publisher · View at Google Scholar
  • Alexander O Shpakov, Kira V Derkach, and Lev M Berstein, “Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases,” Future Science OA, pp. 1–29, 2015. View at Publisher · View at Google Scholar
  • Jong-Jer Lee, Pei-Wen Wang, I-Hui Yang, Chia-Lin Wu, and Jiin-Haur Chuang, “Amyloid-beta mediates the receptor of advanced glycation end product-induced pro-inflammatory response via toll-like receptor 4 signaling pathway in retinal ganglion cell line RGC-5,” The International Journal of Biochemistry & Cell Biology, 2015. View at Publisher · View at Google Scholar
  • Y. Sheena Mary, Hema Tresa Varghese, C. Yohannan Panicker, Thies Thiemann, Abdulaziz A. Al-Saadi, Saheed A. Popoola, C. Van Alsenoy, and Yosef Al Jasem, “Molecular conformational analysis, vibrational spectra, NBO, NLO, HOMO–LUMO and molecular docking studies of ethyl 3-(E)-(anthracen-9-yl)prop-2-enoate based on density functional theory calculations,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, vol. 150, pp. 533–542, 2015. View at Publisher · View at Google Scholar
  • Michele Talley, Erica Pryor, Virginia Wadley, Michael Crowe, Shannon Morrison, and David Vance, “The Physiological Mechanisms of Diabetes and Aging on Brain Health and Cognition: Implications for Nursing Practice and Research,” Journal Of Neuroscience Nursing, vol. 47, no. 5, pp. E12–E22, 2015. View at Publisher · View at Google Scholar
  • Niraj Kumar Jha, Saurabh Kumar Jha, Dhiraj Kumar, Noopur Kejriwal, Renu Sharma, Rashmi K. Ambasta, and Pravir Kumar, “Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer’s Disease Biology: Characterization of Putative Cognates for Therapeutic Applications,” Journal of Alzheimer's Disease, vol. 48, no. 4, pp. 891–917, 2015. View at Publisher · View at Google Scholar
  • Ross Fowkes, Matthew Byrne, Hannah Sinclair, Eugene Tang, and Vijay Kunadian, “Coronary artery disease in patients with dementia,” Coronary Artery Disease, vol. 27, no. 6, pp. 511–520, 2016. View at Publisher · View at Google Scholar
  • Samo Ribarič, “The Rationale for Insulin Therapy in Alzheimer’s Disease,” Molecules, vol. 21, no. 6, pp. 689, 2016. View at Publisher · View at Google Scholar
  • Suzanne M. de la Monte, “Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer’s Disease,” Drugs, 2016. View at Publisher · View at Google Scholar
  • Han-Kyu Lee, Bumsup Kwon, Cynthia A. Lemere, Suzanne de la Monte, Kyohei Itamura, Austin Y. Ha, and Henry W. Querfurth, “mTORC2 (Rictor) in Alzheimer’s Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons,” Journal of Alzheimer's Disease, pp. 1–22, 2016. View at Publisher · View at Google Scholar
  • Noemi Esteras, Carolina Alquezar, Ana de la Encarnacion, and Angeles Martin-Requero, “Lymphocytes in Alzheimer's Disease Pathology: Altered Signaling Pathways,” Current Alzheimer Research, vol. 13, no. 4, pp. 439–449, 2016. View at Publisher · View at Google Scholar
  • Chuanming Wang, John S. Y. Chan, Lijie Ren, and Jin H. Yan, “Obesity Reduces Cognitive and Motor Functions across the Lifespan,” Neural Plasticity, vol. 2016, pp. 1–13, 2016. View at Publisher · View at Google Scholar
  • Canjun Zhu, Pingwen Xu, Yanlin He, Yexian Yuan, Tao Wang, Xingcai Cai, Lulu Yu, Liusong Yang, Junguo Wu, Lina Wang, Xiaotong Zhu, Songbo Wang, Ping Gao, Qianyun Xi, Yongliang Zhang, Yong Xu, Qingyan Jiang, and Gang Shu, “Heparin Increases Food Intake through AgRP Neurons,” Cell Reports, vol. 20, no. 10, pp. 2455–2467, 2017. View at Publisher · View at Google Scholar
  • Lin Li, “The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer’s Disease, Based on a Mechanistic Target of Rapamycin Pathway,” CNS Drugs, 2017. View at Publisher · View at Google Scholar
  • Gisela Esquerda-Canals, Laia Montoliu-Gaya, Jofre Güell-Bosch, and Sandra Villegas, “Mouse Models of Alzheimer’s Disease,” Journal of Alzheimer's Disease, pp. 1–14, 2017. View at Publisher · View at Google Scholar
  • Jun-mei Wang, Ze-qiang Qu, Jin-lang Wu, Peter Chung, and Yuan-shan Zeng, “Mitochondrial protective and anti-apoptotic effects of Rhodiola crenulata extract on hippocampal neurons in a rat model of Alzheimer's disease,” Neural Regeneration Research, vol. 12, no. 12, pp. 2025, 2017. View at Publisher · View at Google Scholar
  • Hyun-Yeol Nam, Sungmin Jun, Kyoungjune Pak, and In Joo Kim, “Concurrent Low Brain and High Liver Uptake on FDG PET Are Associated with Cardiovascular Risk Factors,” Korean Journal of Radiology, vol. 18, no. 2, pp. 392, 2017. View at Publisher · View at Google Scholar
  • Samo Ribarič, “Peptides as Potential Therapeutics for Alzheimer’s Disease,” Molecules, vol. 23, no. 2, pp. 283, 2018. View at Publisher · View at Google Scholar
  • Hsin-Hua Li, Chih-Li Lin, and Chien-Ning Huang, “Neuroprotective effects of statins against amyloid β-induced neurotoxicity,” Neural Regeneration Research, vol. 13, no. 2, pp. 198, 2018. View at Publisher · View at Google Scholar